Peptides designed through molecular dynamics simulations have high affinity for the N‐terminal IDR of p53 and subsequently ameliorate p53 LLPS [98], indicating that the design of peptides is a novel direction for the LLPS-targeted treatment of sepsis. This evidence concerns the gene TP53 and Sepsis.